Following, we used the human SW1417 CRC cell line to assess if the loaded oligo‐FdU conferred cytotoxic activity to the nanoparticle while maintaining its CXCR4 targeting capacity, provided that drug conjugation can alter protein conformation and function (Goswami et al, 2013). The gene discussed is CXCR4; the disease is colorectal carcinoma.